BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23827312)

  • 1. Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens.
    Saini V; Verma SK; Murthy PK; Kohli D
    Vaccine; 2013 Aug; 31(38):4183-91. PubMed ID: 23827312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cell-mediated immune responses elicited by poly (DL-lactide) adjuvanted filarial antigen molecules.
    Saini V; Verma AK; Kushwaha V; Joseph SK; Murthy PK; Kohli D
    Drug Deliv; 2014 May; 21(3):233-41. PubMed ID: 24171405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sufficiency of a single administration of filarial antigens adsorbed on polymeric lamellar substrate particles of poly (L-lactide) for immunization.
    Saini V; Verma SK; Sahoo MK; Kohli DV; Murthy PK
    Int J Pharm; 2011 Nov; 420(1):101-10. PubMed ID: 21855618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii.
    Allahyari M; Mohabati R; Amiri S; Esmaeili Rastaghi AR; Babaie J; Mahdavi M; Vatanara A; Golkar M
    Exp Parasitol; 2016 Nov; 170():236-246. PubMed ID: 27663469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization with anti-inflammatory BmAFI of Brugia malayi allows L3 development in the hostile peritoneal cavity of Mastomys coucha.
    Joseph SK; Verma SK; Sahoo MK; Dixit S; Verma AK; Kushwaha V; Saxena K; Sharma A; Saxena JK; Murthy PK
    Acta Trop; 2011 Dec; 120(3):191-205. PubMed ID: 21875568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR
    Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Vaccine; 2004 Mar; 22(11-12):1423-32. PubMed ID: 15063565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection.
    Sahoo MK; Sisodia BS; Dixit S; Joseph SK; Gaur RL; Verma SK; Verma AK; Shasany AK; Dowle AA; Murthy PK
    Vaccine; 2009 Jul; 27(32):4263-71. PubMed ID: 19450648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.
    Kushwaha V; Tewari P; Mandal P; Tripathi A; Murthy PK
    Parasitol Res; 2019 Jun; 118(6):1849-1863. PubMed ID: 31055672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble
    Margaroni M; Agallou M; Athanasiou E; Kammona O; Kiparissides C; Gaitanaki C; Karagouni E
    Int J Nanomedicine; 2017; 12():6169-6184. PubMed ID: 28883727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against filarial infection by 45-49 kDa molecules of Brugia malayi via IFN-γ-mediated iNOS induction.
    Verma SK; Joseph SK; Verma R; Kushwaha V; Parmar N; Yadav PK; Thota JR; Kar S; Murthy PK
    Vaccine; 2015 Jan; 33(4):527-34. PubMed ID: 25454090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.
    Stanley AC; Buxton D; Innes EA; Huntley JF
    Vaccine; 2004 Sep; 22(29-30):3929-41. PubMed ID: 15364441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
    Luzardo-Alvarez A; Blarer N; Peter K; Romero JF; Reymond C; Corradin G; Gander B
    J Control Release; 2005 Dec; 109(1-3):62-76. PubMed ID: 16269200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
    Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
    APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
    Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
    Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.